Liwei Li

机构：Guangxi Medical University, Peking University, Shanghai Veterinary Research Institute, The People's Hospital of Guangxi Zhuang Autonomous Region, Zhejiang Lab, Peking University People's Hospital, Jikei University Kashiwa hospital, Affiliated Hospital of Hebei University, Hangzhou DAC Biotech (China), Hangzhou First People's Hospital, Hangzhou Medical College, Baoding People's Hospital · ORCID：0009-0001-5978-874X

发表论文 144 篇 · 总被引 1722 次 · h-index 25

代表论文

• Ginsenoside RK1 improves cognitive impairments and pathological changes in Alzheimer's disease via stimulation of the AMPK/Nrf2 signaling pathway (2023 · Phytomedicine · 被引 65)
• Ginsenoside RK3 promotes neurogenesis in Alzheimer's disease through activation of the CREB/BDNF pathway (2023 · Journal of Ethnopharmacology · 被引 28)
• RETRACTED: Parthenolide alleviates cognitive dysfunction and neurotoxicity via regulation of AMPK/GSK3β(Ser9)/Nrf2 signaling pathway (2023 · Biomedicine & Pharmacotherapy · 被引 27)
• Norboldine improves cognitive impairment and pathological features in Alzheimer's disease by activating AMPK/GSK3β/Nrf2 signaling pathway (2024 · Journal of Ethnopharmacology · 被引 19)
• YOD1 regulates microglial homeostasis by deubiquitinating MYH9 to promote the pathogenesis of Alzheimer's disease (2024 · Acta Pharmaceutica Sinica B · 被引 18)
• Pedunculoside alleviates cognitive deficits and neuronal cell apoptosis by activating the AMPK signaling cascade (2024 · Chinese Medicine · 被引 10)